Results 181 to 190 of about 928,680 (341)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Thermo-Priming Mediated Cellular Networks for Abiotic Stress Management in Plants. [PDF]

open access: yesFront Plant Sci, 2022
Khan A   +4 more
europepmc   +1 more source

Spatial Motifs for Device-to-Device Network Analysis (DNA) in Cellular Networks [PDF]

open access: green, 2017
Tengchan Zeng   +3 more
openalex  

Statistical Modeling and Probabilistic Analysis of Cellular Networks With Determinantal Point Processes [PDF]

open access: green, 2015
Yingzhe Li   +3 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Green cellular networks

open access: yes, 2014
Οι περιβαλλοντολογικές αλλαγές που έχουν προκληθεί εξαιτίας της συνεχής ρύπανσης που προκαλεί ο άνθρωπος σε βάρος του οικοσυστήματος είναι τεράστιες και είναι κοινώς αποδεκτό ότι πρέπει να βρεθούν λύσεις όπου να είναι άμεσα εφαρμόσιμες. Στους διάφορους τομείς που επηρεάζουν άμεσα τον περιβάλλον δεν θα μπορούσε να εξαιρεθεί ο τηλεπικοινωνιακός τομέας ...
openaire   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy